FCN2 and acute myeloid leukemia: Despite lack of differences between patients and controls in the frequency of FCN2 genotypes, the median ficolin-2 concentration in the AML group (4.69 μg/ml) was significantly higher than in the controls (3.38 μg/ml, p < 0.000001, Mann–Whitney U-test).